| An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment T Motohara, K Masuda, M Morotti, Y Zheng, S El-Sahhar, KY Chong, ... Oncogene 38 (16), 2885-2898, 2019 | 203 | 2019 |
| Salt-inducible kinase 2 couples ovarian cancer cell metabolism with survival at the adipocyte-rich metastatic niche F Miranda, D Mannion, S Liu, Y Zheng, LS Mangala, C Redondo, ... Cancer cell 30 (2), 273-289, 2016 | 168 | 2016 |
| The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells Z Hu, M Artibani, A Alsaadi, N Wietek, M Morotti, T Shi, Z Zhong, ... Cancer Cell 37 (2), 226-242. e7, 2020 | 153 | 2020 |
| Consequences of resistance evolution in a Cas9-based sex conversion-suppression gene drive for insect pest management EM Carrami, KN Eckermann, HMM Ahmed, S Dippel, JM Marshall, ... Proceedings of the National Academy of Sciences 115 (24), 6189-6194, 2018 | 139* | 2018 |
| Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation Y Zheng, R Sethi, LS Mangala, C Taylor, J Goldsmith, M Wang, K Masuda, ... Nature communications 9 (1), 1-12, 2018 | 60 | 2018 |
| Identification of mutation in GTPBP2 in patients of a family with neurodegeneration accompanied by iron deposition in the brain E Jaberi, M Rohani, GA Shahidi, S Nafissi, E Arefian, M Soleimani, ... Neurobiology of Aging 38, 216. e11-216. e18, 2016 | 58 | 2016 |
| Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease EG Serra, T Schwerd, L Moutsianas, A Cavounidis, L Fachal, S Pandey, ... Nature communications 11 (1), 1-15, 2020 | 56 | 2020 |
| Hyperactive piggyBac transposase improves transformation efficiency in diverse insect species KN Eckermann, HMM Ahmed, EM Carrami, S Dippel, CE Ogaugwu, ... Insect biochemistry and molecular biology 98, 16-24, 2018 | 55 | 2018 |
| Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies K Hellner, F Miranda, DF Chedom, S Herrero-Gonzalez, DM Hayden, ... EBioMedicine 10, 137-149, 2016 | 43 | 2016 |
| Perspective on the combined use of an independent transgenic sexing and a multifactorial reproductive sterility system to avoid resistance development against transgenic … KN Eckermann, S Dippel, EM Carrami, HM Ahmed, IM Curril, EA Wimmer BMC genetics 15 (2), 1-10, 2014 | 34 | 2014 |
| Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells C Taylor, D Mannion, F Miranda, EM Carrami, S Herrero-Gonzalez, ... Oncotarget 8 (11), 17960, 2017 | 27 | 2017 |
| SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers Z Lu, W Mao, H Yang, JM Santiago-O’Farrill, PJ Rask, J Mondal, H Chen, ... The Journal of Clinical Investigation 132 (11), 2022 | 23 | 2022 |
| Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells M Artibani, K Masuda, Z Hu, PC Rauher, G Mallett, N Wietek, M Morotti, ... JCI insight 6 (11), 2021 | 14 | 2021 |
| A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes EM Carrami, S Sharifzadeh, NC Wietek, M Artibani, S El-Sahhar, ... Elife 9, 2020 | 6 | 2020 |
| Season combinatorial intervention predictions with Salt & Peper T Gaudelet, A Del Vecchio, EM Carrami, J Cudini, CA Kapourani, C Uhler, ... arXiv preprint arXiv:2404.16907, 2024 | 1 | 2024 |
| PQA: Zero-shot Protein Question Answering for Free-form Scientific Enquiry with Large Language Models EM Carrami, S Sharifzadeh arXiv preprint arXiv:2402.13653, 2024 | | 2024 |
| High-quality transcriptome profile of Treponema pallidum subsp. pallidum: confirmation of transcriptional landscape L Grillova, EM Carrami, W Roberts-Sengier, NR Thomson bioRxiv, 2024.08. 22.609093, 2024 | | 2024 |
| DigiPico: A whole-genome sequencing approach to investigate microscopic residual chemotherapy resistance disease in ovarian cancer EM Carrami, DC Fotso, Y Zheng, C Yau, A Ahmed Cancer Research 78 (13 Supplement), 2182-2182, 2018 | | 2018 |
| The Oxford Ovarian Cancer Predict Chemotherapy Response (OXO-PCR) study: Understanding the genomic drivers of primary chemotherapy-resistant microscopic residual disease M Artibani, G Mallett, D Sunanda, EM Carrami, M Morotti, S ElSahhar, ... Cancer Research 78 (13 Supplement), 5373-5373, 2018 | | 2018 |
| On the origin, progression, and evolution of ovarian cancer EM Carrami University of Oxford, 2018 | | 2018 |
Ernst A. WimmerProfessor of Developmental Biology, Georg-August-University GoettingenVerified email at gwdg.de
